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Short communication
needing pelvic radiotherapy such as in the case of prostate can-
cer (2). Prostheses should be better taken into account at the 
time of treatment planning and geometrically avoided during 
radiation delivery (3). Several different approaches have been 
proposed to reduce metal artifacts impact during the planning 
process (4). Magnetic resonance imaging (MRI) might be a po-
tential useful tool in this context, facilitating target definition 
and normal structure visualization through CT-MRI coregistra-
tion (5). However, several drawbacks remain, such as different 
patient positioning due to diverse couching systems, eventual 
image distortions, and heterogeneous dose calculation due to 
inaccurate electron density information because of metallic 
implants (5). Cone-beam CT (both kilovoltage CT and megavolt-
age CT) is generally available in modern linear accelerators as 
an on-board imaging system to perform image-guided radio-
therapy (IGRT) (6). Images acquired at these energies are less 
prone to artifacts, as the primary modality of interaction is the 
Compton rather than the photoelectric effect (2). The Clarity 
platform (Clarity System, Elekta, Stockholm, Sweden) allows 
for the acquisition of 3D ultrasound scans (3D-US) of the pelvic 
region (Fig. 1), using a 2D transabdominal probe equipped with 
positional sensors that needs to be swept across the patient’s 
sovrapubic region (7). The system uses an infrared camera to 
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Introduction
Treatment planning for 3D conformal external beam radia-
tion therapy (EBRT) is based on the acquisition of a computed 
tomography (CT) scan in order to acquire patient anatomy 
for treatment volume selection and delineation and electron 
density mapping for proper dose calculation (1). Hip prosthe-
sis is a frequent finding in the subset of patients undergoing 
EBRT, since this type of population is aging. Consequent im-
aging artifacts may represent a challenge in terms of both 
target delineation and dose calculation, especially for patients 
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track sensors’ positional changes, generating spatial informa-
tion subsequently employed to reconstruct a 3D dataset, then 
utilized for target verification and patient alignment during 
IGRT procedures (8). We report on the use of the Clarity sys-
tem for target volume delineation in a consecutive series of 
patients with prostate cancer with bilateral hip replacement 
undergoing definitive EBRT.
materials and methods
Inclusion criteria
Patients diagnosed with organ-confined prostate can-
cer were accrued whenever stratified as intermediate risk 
according to the National Comprehensive Cancer Network 
classification: clinical stage cT2b-cT2c, Gleason sum = 7, and 
prostate-specific antigen (PSA) range 10-20 ng/mL (9). All pa-
tients previously had bilateral hip replacement. They under-
went histologic confirmation and pretreatment evaluation 
(complete medical history, physical examination with digital 
rectal examination, PSA level, multiparametric pelvic MRI). 
Androgen deprivation therapy was allowed in a neoadjuvant, 
concomitant, and adjuvant setting for a total of 4-6 months. 
All patients should have a reliable US visualization of the pros-
tate gland within the Clarity platform and metal artifacts ob-
served during planning CT.
Setup, target volumes, and organs at risk definition
Each patient underwent a planning CT scan of the pelvic 
region for treatment planning. Supine position was used with 
an indexed-shaped knee rest and ankle support (CIVCO Medi-
cal Solutions, Kalona, IA, USA). Three-millimeter axial images 
were acquired from the L5 vertebral body to the ischiatic 
region. An isocenter was found in virtual simulation and its 
projections were marked on the patient’s skin under laser 
guidance. To increase daily reproducibility of setup in terms 
of bladder and rectal filling, all patients were instructed to 
drink 500 mL of water 1 hour before planning CT (as in every 
treatment fraction) and to perform a daily enema in addition 
to a low-residue diet from 3 days prior to simulation. Clini-
cal target volume (CTV) included the entire prostate gland 
and the proximal aspect of the seminal vesicles. Since the 
enrolled patients had important image artifacts due to the 
presence of hip prostheses, a contouring process based only 
on simulation CT images was considered not reliable. Thus, a 
coregistration between planning CT scan and 3D-US images 
was performed and used at the time of treatment volume 
selection and delineation. The consistent soft tissue resolu-
tion of US in adjunct to the independence from metal arti-
facts strongly improved the delineation process. Given that 
US-driven visualization and delineation of the prostate gland 
is a highly operator-dependent process, the contouring pro-
cess was performed only by well-trained physicians. A 10-mm 
margin expansion was added to generate the corresponding 
planning target volumes (PTVs) except in the posterior di-
rection (7 mm), as established in our institutional protocol. 
Outlined organs at risk (OAR) were bladder and rectum (from 
the anal canal to the recto-sigmoid flexure), defined as solid 
organs, bilateral femoral heads, penile bulb, and peritoneal 
cavity, including small bowel. Organs at risk delineation was 
helped with 3D-US coregistration.
Fig. 1 - Axial, sagittal, and coronal view of 3D ultra-
sound imaging.
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Dose prescription, planning, and delivery
All patients received 61.1 Gy/26 fractions (2.35 Gy daily) 
to the seminal vesicles and a total nominal dose of 70.2 Gy/26 
fractions to the prostate gland with a simultaneous integrated 
boost approach. The dose was prescribed following the Interna-
tional Commission of Radiation Units (ICRU 83) recommenda-
tions so that dose distribution was optimized to achieve 98% 
of all PTV receiving at least 95% of the prescription dose, with 
concurrent hot spot minimization (D2%<107% of prescribed 
dose). Dose constraints for OAR were set as follows: V50<35%, 
V60<25%, V65<15%, and V68<5% (rectum), V60<35% and V40<50% 
(bladder), Dmean<50 Gy (penile bulb), D50<40 Gy, D10<50 Gy, and 
D5<60 Gy (peritoneal cavity), Dmax<50 Gy (femoral heads). Radia-
tion was delivered with a static intensity-modulated radiation 
technique employing a 5-field beam arrangement using 10-MV 
photons. The electron density (ED) for dose calculation was set 
to a value of 1 in order to avoid metallic artifacts perturbation 
of dose estimate. A specific 5-field beam arrangement was se-
lected with the aim of avoiding hip prostheses laterally to the 
PTV (gantry angles: 0°, 30°, 160°, 200°, and 330°) (Fig. 3). In 
order to test whether this planning approach was appropriate, 
10 patients with no hip replacement were selected to generate 
corresponding conformal plans with the same beam arrange-
ment, comparing the use of ED override (EDO) with a fixed den-
sity value of 1 to a standard electron density (EDS) approach 
derived from CT to ED calibration curves. Doses to PTV, rectum, 
and bladder were compared by means of specific dose volume 
histogram values. The Clarity 3D-US system (Elekta, Crawley, 
UK) includes 2 separate platforms, located in the CT and treat-
ment room, respectively, and a special dedicated workstation 
for image coregistration and storage. An optical tracking system 
(OTS) is employed to determine the position and orientation of 
the 3D-US probe, registered to the external laser system in both 
rooms, where the paired US data are referenced to the same 
spatial coordinates (7). This mutual referencing robustly corre-
lated the simulation and treatment room coordinate systems. 
After simulation CT scan, a free-hand axial sweep is acquired, 
reconstructed, and employed to create 3D-US images using 
the detection performed by the OTS of an array of infrared re-
flectors connected to the probe handle. The acquisition of US 
images within the CT room coordinate system, driven by laser 
coordinates, allows for automatic registration between the dif-
ferent acquisitions at the Clarity workstation. However, the final 
registration is manually adjustable by the operator. A guidance 
structure is created, called positioning reference volume (PRV), 
within the Clarity workstation to be used as reference in the 
treatment room. During each treatment fraction, a free-hand 
axial sweep is acquired and then segmented into axial and sagit-
tal planes (Fig. 1). Thereafter, the treatment PRV is automatically 
aligned with the reference PRV using an optimization algorithm 
based on gray values and thereafter manually by the operator. 
When the alignment is considered appropriate, the system au-
tomatically takes into account final target displacements with a 
couch translation alongside the 3 spatial vectors (8).
results
3D-US coregistration with simulation CT scan was able 
to minimize image artifacts due to high-density metal hip 
implants in all 4 patients, providing better evidence of pa-
tient anatomy, particularly in terms of soft tissue visualization 
(Fig. 2 and Fig. 3). Both prostate gland and the proximal por-
tion of seminal vesicles were successfully delineated using the 
hybrid image. Interestingly, the imaging artifacts on the CT scan 
due to hip prostheses hid the posterior aspect of the prostate 
as the anterior rectal wall, potentially rendering difficult the 
visualization of the interface between these 2 structures. The 
same issue happened for the base of the prostate and the blad-
der neck. 3D-US was useful in the delineation of these specific 
regions. Also, the contouring process of the lateral extensions 
of the prostate gland and the seminal vesicles was enhanced by 
the use of 3D-US. The OAR such as rectum and bladder were de-
lineated with higher accuracy. No difference was found in terms 
of average PTV dose, D15%, or D25% for rectum or D15%, D25%, or 
D35% for bladder (see Tab. I and Fig. 4 for details) between the 2 
approaches (EDO vs EDS).
Discussion
Radiation dose escalation has been proved to provide clini-
cal benefit to patients with prostate cancer (10). In this context, 
correct and precise identification of both target volumes and 
critical structures are mandatory for accuracy and reliability of 
dose calculation (11). Several methods have been shown to 
provide a potential tool to deal with the issue of a poorly visu-
alized anatomical region, with a tight dependence on the type 
of equipment available (12). Megavoltage CT used for planning 
purposes is able to consistently reduce image streaks, but re-
quires intraprostatic fiducial marker implantation to enhance 
organ delineation (2). Magnetic resonance imaging has been 
demonstrated to improve delineation precision, but carries a 
tendency for geometric distortions, particularly prone to bi-
ases due to prostheses heterogeneity (5). Cone-beam CT (kilo-
voltage CT) has effective metal artifact-suppressing algorithms, 
even if the impact of metal artifacts may be magnified within 
the soft tissue region, given that the contrast of soft tissue is 
generally lower in cone-beam CT images. The Clarity platform, 
employing 3D-US, provides reliable imaging of patient anato-
my even in the presence of hip replacement, as shown in our 
report. This information may be used to compensate for that 
missing in the CT scan and due to artifacts to drive target vol-
ume and OAR selection and delineation. Also, segmentation 
for planning purposes may be facilitated, increasing ballistic 
precision and reliability of the treatment process. All these 
methods have pros and cons as applied for prostate gland vi-
sualization in the presence of hip prostheses. Kilovoltage cone-
beam CT may have the drawback of a higher impact of artifact 
presence on images because of the aforementioned lower 
soft tissue contrast (13). Megavoltage cone-beam CT may not 
necessarily guarantee a consistent spatial resolution due to 
high noise-to-signal ratio and low soft tissue contrast. Mag-
netic resonance imaging may have significant image distortion 
due to artifacts. On the contrary, 3D-US is less conditioned 
by these issues if employed in the contouring process. Per-
turbations of the dose distribution by hip prostheses during 
 radiotherapy treatment of pelvic malignancies may result in 
unacceptable dose inhomogeneity within the target volume. 
Such an inhomogeneous dose distribution may compromise 
local control and, therefore, specific beam arrangements 
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aiming at avoiding those medical devices have been proposed 
(14). It is possible that this need may lead to a selection of less-
than-ideal geometry with unintended excessive dose to OAR. 
Intensity-modulated radiotherapy (IMRT), with the possibility 
to generate abrupt dose falloffs, may be a viable tool to com-
pensate for this issue. The differences shown by calculations 
without using heterogeneity correction (EDO) or using the CT 
to ED correction (EDS) for a standard conformal plan was not 
statistically significant for PTV and OAR, showing a negligible 
Fig. 3 - Dose distribution after treatment planning.
tabLE i -  Difference in dose calculation between electron density 
override and standard electron density
PtV Rectum bladder
Patient average D15% D25% D15% D25% D35%
1 -1.3 -0.8 -1.1 -2.2 -1.9 1.2
2 0.1 0.3 0.5 0.2 0.0 0.0
3 -0.3 -0.3 -0.2 -0.5 0.0 0.0
4 -0.2 0.1 0.0 -0.7 -0.6 -0.8
5 -1.0 -0.9 -0.9 -1.2 -1.3 -1.7
6 -0.1 -0.2 2.8 -0.4 -0.5 -0.5
7 0.3 0.4 0.5 -0.2 0.1 0.0
8 -1.3 0.3 0.4 0.0 0.1 0.0
9 1.4 0.2 0.1 -0.6 -0.7 -0.3
10 -1.2 -0.9 -0.9 -1.7 -1.6 -0.2
PTV = planning target volume.
p = NS.
impact of heterogeneity calculation within the abdominal re-
gion. Thus, we selected static IMRT avoiding prostheses and 
using no heterogeneity correction for dose calculation within 
the metal artifact regions. 3D-US-driven IGRT requires an ini-
tial mandatory learning curve and strongly depends on the 
Fig. 2 - Coregistration between 3D ultrasounds and 
planning computed tomography.
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operator’s experience in terms of US image acquisition, visu-
alization, and coregistration. Also, certain patients should be 
excluded from this technique because of low visibility of the 
prostate gland due to obesity. Finally, it has been demonstrat-
ed that the US probe may impact in terms of prostate localiza-
tion due to operator pressure even within an intramodality re-
positioning device (15). The consequent uncertainties should 
be taken into account during CTV to PTV margin generation. 
Despite these limitations, 3D-US has shown to be a useful and 
reliable tool to enhance target volume and OAR visualization 
in patients with prostate cancer undergoing EBRT and having 
bilateral hip replacement.
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